Showing 61 - 80 results of 379 for search '"The New England Journal of Medicine"', query time: 0.29s Refine Results
  1. 61
  2. 62

    Allogeneic transplantation following non-myeloablative conditioning in renal carcinoma. New evidence of the immune mechanisms responsible for the activity of this form of immunothe... by Camillo Porta

    Published 2011-12-01
    “…In 2000, the influential New England Journal of Medicine published the first impressive results of the use of allogeneic stem cell transplantation following nonmyeloblative conditioning (the so-called ‘mini-allo transplant’) in the treatment of patients with advanced kidney cancer...…”
    Get full text
    Article
  3. 63
  4. 64
  5. 65

    Allogeneic transplantation following non-myeloablative conditioning in renal carcinoma. New evidence of the immune mechanisms responsible for the activity of this form of immunothe... by Camillo Porta

    Published 2011-12-01
    “…In 2000, the influential New England Journal of Medicine published the first impressive results of the use of allogeneic stem cell transplantation following nonmyeloblative conditioning (the so-called ‘mini-allo transplant’) in the treatment of patients with advanced kidney cancer...…”
    Get full text
    Article
  6. 66

    COVID-19: Measles and Antibiotic Resistance Are a Matter of Concern by Giovanni Di Guardo

    Published 2021-04-01
    “…An interesting Perspective article recently published in the <i>New England Journal of Medicine</i> offers an insightful overview on the benefits provided by the mass vaccination of children against Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2), the betacoronavirus responsible for the dramatic CoronaVirus Disease-2019 (COVID-19) pandemic [...]…”
    Get full text
    Article
  7. 67
  8. 68

    Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis by Hopewell, S, Ravaud, P, Baron, G, Boutron, I

    Published 2012
    “…The change in level or trend did not increase in journals with no policy to enforce the guidelines (BMJ, JAMA, and New England Journal of Medicine).</p> <p><strong>Conclusion</strong> Active implementation of the CONSORT for Abstracts guidelines by journals can lead to improvements in the reporting of abstracts of randomised trials.…”
    Journal article
  9. 69

    Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. by Hopewell, S, Ravaud, P, Baron, G, Boutron, I

    Published 2012
    “…The change in level or trend did not increase in journals with no policy to enforce the guidelines (BMJ, JAMA, and New England Journal of Medicine). CONCLUSION: Active implementation of the CONSORT for Abstracts guidelines by journals can lead to improvements in the reporting of abstracts of randomised trials.…”
    Journal article
  10. 70

    Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 2 by Kenji Yamamoto

    Published 2021-09-01
    “…Abstract Recently, heparin-induced thrombocytopenia (HIT) after vaccination with the vaccines manufactured by AstraZeneca and Pfizer–BioNTech has been published in the New England Journal of Medicine. These reports state that heparin was not used around the vaccination period in all cases. …”
    Get full text
    Article
  11. 71

    Laying ethical foundations for clinical research by Jon Harkness, Susan E. Lederer, Daniel Wikler

    “…The original article is reproduced from The New England Journal of Medicine by permission of the Massachusetts Medical Society.…”
    Get full text
    Article
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76

    Women and STEMI: a shared responsibility by Miren Telleria Arrieta

    Published 2020-02-01
    “…Back in 1991 the New England Journal of Medicine published an editorial1 on this matter. …”
    Get full text
    Article
  17. 77

    Research Trends and Most Influential Clinical Studies on Anti-PD1/PDL1 Immunotherapy for Cancers: A Bibliometric Analysis by Yanhao Liu, Yan Xu, Xi Cheng, Yaru Lin, Shu Jiang, Haiming Yu, Zhen Zhang, Linlin Lu, Xiaotao Zhang

    Published 2022-04-01
    “…In summary, anti-PD1/PDL1 has become standard treatment for various cancer, while adjuvant anti-PD1/PDL1 therapy is currently a research hotspot. New England Journal of Medicine was identified as the most influential journal in this area. …”
    Get full text
    Article
  18. 78
  19. 79

    Spread of artemisinin resistance in plasmodium falciparum malaria by Tripura, Rupam, Borrmann, Steffen, Bashraheil, Mahfudh, Peshu, Judy, Faiz, M. Abul, Ghose, Aniruddha, Hossain, M. Amir, Samad, Rasheda, Rahman, M. Ridwanur, Valecha, Neena, Phyo, Aung Pyae, Venkatesan, Meera, Mishra, Neelima, Yi, Poravuth, Ashley, Elizabeth A., Dhorda, Mehul, Fairhurst, Rick M., Amaratunga, Chanaki, Lim, Parath, Suon, Seila, Sreng, Sokunthea, Anderson, Jennifer M., Mao, Sivanna, Sam, Baramey, Sopha, Chantha, Chuor, Char Meng, Nguon, Chea, Sovannaroth, Siv, Pukrittayakamee, Sasithon, Jittamala, Podjanee, Chotivanich, Kesinee, Chutasmit, Kitipumi, Suchatsoonthorn, Chaiyaporn, Runcharoen, Ratchadaporn, Hien, Tran Tinh, Thuy-Nhien, Nguyen Thanh, Thanh, Ngo Viet, Phu, Nguyen Hoan, Htut, Ye, Han, Kay-Thwe, Aye, Kyin Hla, Mokuolu, Olugbenga A., Olaosebikan, Rasaq R., Folaranmi, Olaleke O., Mayxay, Mayfong, Khanthavong, Maniphone, Hongvanthong, Bouasy, Newton, Paul N., Onyamboko, Marie A., Fanello, Caterina I., Tshefu, Antoinette K., Nosten, Francois, Hasan, M. Mahtabuddin, Islam, Akhterul, Miotto, Olivo, Amato, Roberto, MacInnis, Bronwyn, Stalker, Jim, Kwiatkowski, Dominic P., Bozdech, Zbynek, Jeeyapant, Atthanee, Cheah, Phaik Yeong, Sakulthaew, Tharisara, Chalk, Jeremy, Intharabut, Benjamas, Silamut, Kamolrat, Lee, Sue J., Vihokhern, Benchawan, Kunasol, Chanon, Imwong, Mallika, Tarning, Joel, Taylor, Walter J., Yeung, Shunmay, Woodrow, Charles J., Flegg, Jennifer A., Das, Debashish, Smith, Jeffery, Plowe, Christopher V., Stepniewska, Kasia, Guerin, Philippe J., Dondorp, Arjen M., Day, Nicholas P., White, Nicholas J.

    Published 2015
    Get full text
    Get full text
    Journal Article
  20. 80

    Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all by Benjamin L Maughan, Emmanuel S Antonarakis

    Published 2014-12-01
    “…In a study recently published by Beer et al. [1] in the New England Journal of Medicine, another advance to treatment was demonstrated for the androgen receptor (AR) signaling inhibitor, enzalutamide, in patients with chemotherapy-naïve metastatic CRPC. …”
    Get full text
    Article